The following is a summary of “Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and ...

The US Food and Drug Administration (FDA) has lifted the partial clinical hold on Vigil Neuroscience’s Phase I trial of ...

WATERTOWN, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VIGL), a clinical-stage biotechnology company committed to ...

Claims around indulgence are pegged for future growth, with younger and active consumers leading demand. Texturizers and fats deliver a desirable mouthfeel and enhanced flavors, while healthier oils, ...

This study aimed to establish relations between calcified deposits in renal papillae and the development and morphology of corresponding COM papillary renal calculi.

Ovarian cancer is a relatively manageable malignancy when diagnosed at an early stage, but late-stage detection almost always translates into a poor prognosis. Researchers have been vigorously ...

Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...